RENEURON GROUP PLC

Delayed London Stock Exchange  - 
- GBX   -.--%
06/14WALL STREET STOCK EXCHANGE : A 0.75% rate hike is getting likelier
06/14ANALYST RECOMMENDATIONS : NetApp, Nike, Oracle, Wizz Air, Walmart...
03/22Reneuron Group plc Announces Directorate Changes
CI
SummaryNewsRatingsCalendarCompany 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about RENEURON GROUP PLC
03/22Reneuron Group plc Announces Directorate Changes
CI
02/11ReNeuron CEO to Step Down at February-End
MT
02/11ReNeuron Group plc Announces CEO Changes, Effective 28 February 2022
CI
02/11ReNeuron Group plc Announces Leaving of Olav Hellebø as Executive Director
CI
02/04TRANSCRIPT : ReNeuron Group plc - Special Call
CI
01/18ReNeuron Down 39% After Out-Licensing Retinitis Pigmentosa Program
MT
01/18ReNeuron Group plc Provides Strategic Update
CI
01/13ReNeuron, Fosun Supplement Stroke Drug Licensing Deal For Potential Technology Transfer
MT
01/13Reneuron Group plc Announces Additional Agreement with Fosun Pharma for CTX
CI
2021RENEURON : Interim Statement 2021
PU
2021TRANSCRIPT : ReNeuron Group plc, H1 2022 Earnings Call, Nov 30, 2021
CI
2021TRANSCRIPT : ReNeuron Group plc, H1 2022 Earnings Call, Nov 30, 2021
CI
2021Earnings Flash (RENE.L) RENEURON GROUP Reports H1 Revenue GBP58,000
MT
2021Earnings Flash (RENE.L) RENEURON GROUP Posts H1 Loss GBX-9.20
MT
2021ReNeuron Group plc Reports Earnings Results for the Half Year Ended September 30, 2021
CI
More most relevant news
All news about RENEURON GROUP PLC
06/14WALL STREET STOCK EXCHANGE : A 0.75% rate hike is getting likelier
06/14ANALYST RECOMMENDATIONS : NetApp, Nike, Oracle, Wizz Air, Walmart...
03/22Reneuron Group plc Announces Directorate Changes
CI
02/11ReNeuron CEO to Step Down at February-End
MT
02/11ReNeuron Group plc Announces CEO Changes, Effective 28 February 2022
CI
02/11ReNeuron Group plc Announces Leaving of Olav Hellebø as Executive Director
CI
02/07Adverum Biotechnologies Names Chief Medical Officer
MT
02/04TRANSCRIPT : ReNeuron Group plc - Special Call
CI
01/18ReNeuron Down 39% After Out-Licensing Retinitis Pigmentosa Program
MT
01/18ReNeuron Group plc Provides Strategic Update
CI
More news
News in other languages on RENEURON GROUP PLC
06/14BOLSA DE MADRID : Los osos son liberados
06/14Les ours sont lâchés
06/14AVIS D'ANALYSTES DU JOUR : LVMH, Kering, Michelin, Scor, Verbund, Swatch, Adidas, Nokia, G..
03/22Reneuron Group plc annonce des changements de direction
02/11Le PDG de ReNeuron se retire à la fin du mois de février
02/11ReNeuron Group plc annonce des changements de PDG, à compter du 28 février 2022
02/11ReNeuron Group plc annonce le départ d'Olav Hellebø ; en tant que directeur exécu..
02/07Adverum Biotechnologies nomme un directeur médical en chef
01/18ReNeuron en baisse de 39 % après l'octroi d'une licence pour son programme sur la rétin..
01/18ReNeuron Group plc présente une mise à jour stratégique
More news
Analyst Recommendations on RENEURON GROUP PLC
06/14ANALYST RECOMMENDATIONS : NetApp, Nike, Oracle, Wizz Air, Walmart...
More recommendations
Press releases
2021RENEURON : Interim Statement 2021
PU
2021RENEURON : New CTX-iPSC platform data shows potential in Peripheral Nerve Repair
PU
2021RENEURON : Collaboration agreement with UCL
PU
2021RENEURON : First subject treated at Oxford Eye Hospital in Phase 2a RP trial
PU
2021RENEURON : Further changes in the Board of Directors
PU
More press releases
Upcoming event on RENEURON GROUP PLC